Enhanced activity of osteoblast differentiation factor (PEBP2αA2/CBFa1) in affected sutural osteoblasts from patients with nonsyndromic craniosynostosis

Cleft Palate-Craniofacial Journal

Volumn 38, Issue 6, 2001, Pages 606-614

  Shevde, N K ^a   Bendixen, A C ^a   Maruyama, M ^a   Li, B L ^a   Billmire, D A ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Bone; Cbfa1; Craniosynostosis; Nonsyndromic osteoblasts

Indexed keywords

DIFFERENTIATION INDUCING FACTOR; MESSENGER RNA; OSTEOBLAST DIFFERENTIATION FACTOR; OSTEOCALCIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CRANIAL SUTURE; CRANIOFACIAL SYNOSTOSIS; FEMALE; GENE TRANSFER; GENETIC TRANSCRIPTION; HISTOLOGY; HUMAN; HUMAN TISSUE; INFANT; MALE; NORTHERN BLOTTING; OSSIFICATION; OSTEOBLAST; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROMOTER REGION;

NON-PROGRAMMATIC;

ALKALINE PHOSPHATASE; ANALYSIS OF VARIANCE; BLOTTING, NORTHERN; CALCIFICATION, PHYSIOLOGIC; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL DIVISION; COLORING AGENTS; CONNECTIVE TISSUE; CORE BINDING FACTOR ALPHA 1 SUBUNIT; CRANIAL SUTURES; CRANIOSYNOSTOSES; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INFANT; MALE; NEOPLASM PROTEINS; OSTEOBLASTS; OSTEOCALCIN; OSTEOGENESIS; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; STATISTICS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 0035173430     PISSN: 10556656     EISSN: None     Source Type: Journal    
DOI: 10.1597/1545-1569(2001)038<0606:EAOODF>2.0.CO;2     Document Type: Article

References (46)

1. Establishment and hormonal regulation of a conditionally transformed preosteocytic cell line from adult human bone
2. Increased IGF-I and IGF-II mRNA and IGF-I peptide in fusing rat cranial sutures suggest evidence for a paracrine role of insulin-like growth factors in suture fusion
3. Studies in cranial suture biology: Regional dura mater determines the in vitro cranial suture fusion
4. Pigments, minerals, cytoplasmic granules
5. Analysis of osteocalcin expression in transgenic mice reveals a species difference in vitamin D regulation of mouse and human osteocalcin genes
6. Sutural biology and the correlates of craniosynostosis
7. Transforming growth factor βs and fibroblast growth factors and their receptors: Role in sutural biology and craniosynostosis
8. Genetic control of cell differentiation in the skeleton
9. A Cbfa1-dependent genetic pathway controls bone formation beyond embryo development
10. Ost2/Cbfa1: A transcriptional activator of osteoblast differentiation
11. Genomic organization, expression of the human CBFA1 gene, and evidence for an alternative splicing event affecting protein function
12. Development and validation of a radioimmunoassay for mouse osteocalcin: Paradoxical response in the Hyp mouse
13. Cbfa1 isoforms exert functional differences in osteoblast differentiation
14. Transcriptional activation and dimerization functions in the human vitamin D receptor
15. The genetic transformation of bone biology
16. Sequence elements in the human osteocalcin gene confer basal activation and inducible response to hormonal vitamin D
17. The TGF-β superfamily: New members, new receptors, and new genetic tests for function in different in organisms
18. The biology of sutures
19. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrests of osteoblasts
20. Genetic study of nonsyndromic coronal craniosynostosis
21. Transcriptional control of osteoblast differentiation
22. Elevated levels of transforming growth factor beta 2 and beta 3 in lambdoid sutures from children with persistent plagiocephaly
23. Human osteoblastic cells: A potential tool to assess the etiology of pathologic bone formation
24. Culture and behavior of osteoblastic cells isolated from normal trabecular bone surfaces
25. The transforming growth factor-β family
26. The mammalian basic helix-loop-helix protein HES-I binds to and modulates transactivating function of the runt-related factor Cbfa1
27. The synthesis of collagenase, gelatinase-A (72 kDa) and -B (95 kDa), and TIMP-I and-2 by human osteoblasts from normal and arthritic bone
28. Malformations of the central nervous system
29. Structural organization of the human vitamin D receptor chromosomal gene and its promoter
30. Studies in cranial suture biology: Up-regulation of transforming growth factor-beta i and basic fibroblast growth factor mRNA correlates with posterior frontal cranial suture in rat
31. Influence of fixation and decalcification on the immunohistochemical staining of cell specific markers in paraffin-embedded human bone biopsies
32. Cranial suture obliteration is induced by removal of transforming growth factor (TGF)-beta 3 activity and prevented by removal of TGF-beta 2 activity from fetal rat calvaria in vitro
33. TGF-beta 1, TGF-beta 2, and TGF-beta 3 exhibit distinct patterns of expression during cranial suture formation and obliteration in vivo and in vitro
34. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development
35. The genomic mechanism of action of 1,25-dihydroxyvitamon D3
36. Increased bone formation and osteoblastic cell phenotype in premature cranial suture ossification (craniosynostosis)
37. Fibroblast growth factor receptor 3 mutation in nonsyndromic coronal synostosis: Clinical spectrum, prevalence, and surgical outcome
38. Studies in cranial suture biology: Part 1. Increased immunoreactivity for TGF-beta isoforms (beta 1, beta 2, and beta 3) during rat cranial suture fusion
39. Evaluation of molecular and cellular signals in nonsyndromic craniosynostosis
40. Nuclear structure-gene expression interrelationships: Implications for aberrant gene expression in cancer
41. Bone
42. Inhibition of osteoblast-specific transcription factor Cbfa1 by the cAMP pattern in osteoblastic cells
43. Craniosynostosis: Genes and mechanisms
44. Osteoblastic and osteoclastic activation in coronal sutures undergoing fusion ex vivo
45. MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor Cbfa1